Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Fenofibrate and Metformin for Atherogenic Dyslipidemia (FAMA) Study

NCT00400231 is registered in ClinicalTrials.gov with University of Pennsylvania as lead sponsor.

NCT NCT00400231
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00400231 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Fenofibrate and Metformin for Atherogenic Dyslipidemia (FAMA) Study
Lead sponsor
University of Pennsylvania
Phase
Phase 2
Overall status
Completed
Start date
August 31, 2005
Completion date
March 31, 2008
Enrollment
124 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metabolic syndrome x